A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

Condition:   Pneumococcal Disease Interventions:   Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: control pneumococcal polysaccharide vaccine Sponsor:   Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials